As federal guidance changes and supply conditions stabilize, clinics are facing new questions about sourcing, prescribing, compliance, and patient communication
The concerns about a potential link between GLP-1 receptor agonists and thyroid cancer largely stem from early animal studies
Among those receiving tirzepatide, 98.5% lost at least 5% of their body weight from baseline to 88 weeks, 94% lost at least 10% of their body weight, 87.1% lost at least 15% of their body weight, 72.6% achieved a 20% or higher weight loss and 56.6% had a weight reduction of at least 25%
Studies on lipoate effects on blood redox state in human immunodeficiency virus infected patients
Hurry up and give it a try
Aragn F, Karaca M, Novials A, Maldonado R, Maechler P, Rub B